ACS Publications. Most Trusted. Most Cited. Most Read
My Activity
CONTENT TYPES
RETURN TO ISSUEPREVResearch ArticleNEXT

GeneGuard: A Modular Plasmid System Designed for Biosafety

View Author Information
Centre for Synthetic Biology and Innovation, Imperial College London, London SW7 2AZ, United Kingdom
Department of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom
*Phone: +44 0 20 7594 7615. Fax: +44 0 20 7594 9817. Email: [email protected]
Cite this: ACS Synth. Biol. 2015, 4, 3, 307–316
Publication Date (Web):May 13, 2014
https://doi.org/10.1021/sb500234s

Copyright © 2022 American Chemical Society. This publication is licensed under CC-BY.

  • Open Access

Article Views

7202

Altmetric

-

Citations

LEARN ABOUT THESE METRICS
PDF (3 MB)
Supporting Info (3)»

Abstract

Synthetic biology applications in biosensing, bioremediation, and biomining envision the use of engineered microbes beyond a contained laboratory. Deployment of such microbes in the environment raises concerns of unchecked cellular proliferation or unwanted spread of synthetic genes. While antibiotic-resistant plasmids are the most utilized vectors for introducing synthetic genes into bacteria, they are also inherently insecure, acting naturally to propagate DNA from one cell to another. To introduce security into bacterial synthetic biology, we here took on the task of completely reformatting plasmids to be dependent on their intended host strain and inherently disadvantageous for others. Using conditional origins of replication, rich-media compatible auxotrophies, and toxin–antitoxin pairs we constructed a mutually dependent host-plasmid platform, called GeneGuard. In this, replication initiators for the R6K or ColE2-P9 origins are provided in trans by a specified host, whose essential thyA or dapA gene is translocated from a genomic to a plasmid location. This reciprocal arrangement is stable for at least 100 generations without antibiotic selection and is compatible for use in LB medium and soil. Toxin genes ζ or Kid are also employed in an auxiliary manner to make the vector disadvantageous for strains not expressing their antitoxins. These devices, in isolation and in concert, severely reduce unintentional plasmid propagation in E. coli and B. subtilis and do not disrupt the intended E. coli host’s growth dynamics. Our GeneGuard system comprises several versions of modular cargo-ready vectors, along with their requisite genomic integration cassettes, and is demonstrated here as an efficient vector for heavy-metal biosensors.

Current microbial synthetic biology systems are predominantly built for use in contained bioreactors, for example, for the production of valuable compounds. (1) Other applications, by their very nature, are proposed for use outside the confines of a laboratory (e.g., biosensors, (2) bioremediation, (3) and biomining). (4) This leads to understandable concern over the release of genetically modified microbes (GMMs), including their unchecked proliferation and the possibility of “genetic pollution”, (i.e., the undesired establishment of synthetic genetic material in other organisms).
In the past three decades, researchers have developed a catalogue of approaches for engineering microbes with the intention to address such GMM biosafety issues (e.g., “kill-switches”, auxotrophies). Two recent reviews described the strengths and weaknesses of these methods with respect to synthetic biology (5, 6) and highlighted how complete genomic recoding (7) and “xenobiology” (8) may offer solutions for the future. However, given that such technologies are in their infancy, a here-and-now solution is essential for biosensors and related GMM projects that are currently underway. In this work, we seek to fulfill this need by combining existing biosafety devices into what we believe is a robust strategy to counter unwanted horizontal gene transfer (HGT) of synthetic DNA.
Working with E. coli, we describe a plasmid-based system linked to its intended host strain via three separate mechanisms to ensure system redundancy. Although plasmids are extensively used in both synthetic biology and industrial biotechnology, as mobile genetic elements they are inherently an environmental biosafety concern (e.g., antibiotic resistance spread). Despite this, they offer two crucial advantages over the alternative strategy of placing synthetic genes into the host microbe genome: (i) they are easier to construct, test and tune compared to genomically integrated DNA; and (ii) via imperfect retention and/or a lack of selection, (9) they have a limited half-life when deployed into an environment. Furthermore, synthetic DNA placed within plasmids is not flanked by native genomic sequences, as it is with genomically integrated constructs. Such native flanking sequence gives the potential for synthetic DNA to homologously recombine into unmodified strains that possess significant genome homology to the intended host.
Our plasmid system, called GeneGuard, focuses on three device classes that lead to host-plasmid mutual dependency: (i) a conditional origin of replication (COR), in which the requisite plasmid replication initiator protein is provided in trans; (ii) complementation of an introduced host auxotrophy, with compatibility for use in common rich-media; and (iii) plasmid-encoding of a broad-spectrum toxin to select against plasmid spread by making the plasmid DNA itself disadvantageous to maintain by a wild-type bacterium. Importantly, GeneGuard does not need to utilize antibiotic resistance cassettes.
We assemble combinations of these devices using the Standard European Vector Architecture (SEVA (10)), and tune their expression using BIOFAB bicistronic domains. (11) The result is a collection of new “secure” plasmids that are able to replace those used as the vector DNA for most E. coli synthetic biology projects. We examine here their efficiency for use in the lab and provide a preliminary assessment of their compatibility for use in soil. Selected devices are also examined for their effects on host growth rate, and their ability to inhibit horizontal gene transfer is assessed via electroporation into E. coli and natural transformation into supercompetent Bacillus subtilis. (12) Finally, as a proof-of-principle, we show that heavy-metal biosensors built and hosted on commonly used plasmid vectors perform as well, if not better, in the GeneGuard system.

Results and Discussion

ARTICLE SECTIONS
Jump To

To build the GeneGuard system we took three biosecurity device classes (CORs, auxotrophy complementation and toxin–antitoxin pairs), tested their functionality in E. coli, and combined them into a set of customizable plasmids built upon the modular SEVA plasmid architecture. (10)

Conditional Origins of Replication (CORs)

Using pSEVA111 (10) as a starting point, constitutive mRFP1 reporter vectors containing either the R6K (13) or ColE2 (-P9) (14) COR were built (pSEVA117Rb and pSEVA177Rb) and transformed into three different tunable plasmid copy number “DIAL” strain variants. (15) As a proxy for confirming copy number control, fluorescent output was assessed by flow cytometry (Figure 1; see Supporting Information Table 1 for comprehensive plasmid and strain details). Low-level expression of the replication initiator proteins for R6K and ColE2 (π and RepA, respectively) in DIAL strain AB resulted in near background levels of observable fluorescence. Medium-level expression (DIAL strain EI) gave an output higher than that observed from a low-copy number RK2 origin control (pSEVA127Rb; ∼4–15 per cell (16)), while R6K/ColE2 plasmids hosted under a high level of π/RepA expression (DIAL strain JK; previously unpublished) resulted in equivalent or greater fluorescence than that observed from a high-copy number pUC origin control (pSEVA167Rb; ∼100 per cell (17, 18)). These results are consistent with the original DIAL strain data, which correlated well to quantitative PCR estimation of plasmid copy number. (15) Furthermore, the inability of these CORs to propagate in the absence of π or RepA was confirmed through repeatedly unsuccessful attempts to transform wild-type E. coli (i.e., no colonies were obtained unless DIAL strains were used). This confirms that COR plasmid replication is dependent on a specific host, thereby inhibiting establishment in other microbes.

Figure 1

Figure 1. Flow cytometry of DIAL strains hosting COR reporter plasmids. (a) Schematic of COR plasmid dependence on host DIAL strain, where plasmid copy number is tuned by the ribosome binding site (RBS) strength of the replication initiator protein transcript. (b) DIAL strains constitutively expressing both π and RepA at low (AB), medium (EI) and high (JK) levels were transformed with mRFP1 reporter plasmids containing the R6K (pSEVA117Rb) or ColE2 (pSEVA177Rb) COR, and fluorescence assessed at mid log growth phase by flow cytometry. Low-copy RK2 (pSEVA127Rb) and high-copy pUC (pSEVA167Rb) origins were also profiled as controls. Median fluorescence values and robust coefficient of variation (rCV) are indicated beneath each plot (n = 4 biological repeats; representatives shown). W/T, wild-type E. coli MC1061 used for DIAL strain construction; au, arbitrary units; X-axis, side scatter; RBS EI, RBS E for π, RBS I for RepA (see Supporting Information Table 1 for more detail).

Rich-media Compatible Auxotrophs

The use of antibiotic resistance genes is inappropriate for environmental applications not only due to concerns over HGT but also because of the impracticality of continually applying a selective agent to a GMM-deployed area. An alternative strategy for host-plasmid dependency is auxotrophic complementation. Common auxotrophies (e.g., amino acid biosynthesis knockouts) usually require defined minimal-media to ensure key metabolite absence, and typically result in a decreased growth rate. Of greater utility are auxotrophs compatible with rich-media (e.g., LB), such as knockouts in E. coli for thymidine (ΔthyA) (19) or diaminopimelic acid (DAP; ΔdapA). (20) Rich-media supplementation with small quantities of these metabolites supports the growth of knockouts, as does complementation via introduction of a plasmid carrying the relevant knocked-out gene.
Using the DIAL strains as a starting chassis, ΔthyA or ΔdapA auxotrophs were created using the λ Red recombinase method, (21, 22) and integrants were verified by colony PCR. These auxotrophs were unable to grow in LB medium unless supplemented with the appropriate key metabolite. To complement these knockouts, the thyA and dapA open reading frames were amplified from E. coli MC1061 and separately inserted into the R6K and ColE2 COR reporter plasmids (after SEVA (10) and BioBrick (23) incompatible restriction sites had been removed, giving pSEVA117RbT or D, pSEVA177RbT or D). BIOFAB constitutive promoters and bicistronic designs (BCDs), configured for reliable levels of gene expression, (11) were used to heuristically tune thyA and dapA expression. Promoter P14 coupled to BCD7 was picked as a prospective medium-strength combination and was found to be suitable for low-copy DIAL strain auxotroph complementation. In medium or high-copy DIAL strain auxotrophic variants; however, transformants were not obtainable. A second iteration using the weaker promoter P12 (∼65% strength of P14) was found to exhibit wild-type growth characteristics in all DIAL strains used, indicating that a reasonable range of thymidylate synthase (thyA) or 4-hydroxy-tetrahydrodipicolinate synthase (dapA) is sufficient for key metabolite production.
The stability of our thyA/dapA plasmids was assessed at a low-copy number (DIAL strain AB), with their complementation of the introduced auxotrophy acting as sole selection pressure (Figure 2b). In the absence of selection, the probability of each daughter cell receiving a plasmid from its mother is not sufficient to support indefinite propagation in a population over time. This was confirmed by the R6K and ColE2 COR reporter plasmids (pSEVA117Rb and pSEVA177Rb) showing near complete depletion after ∼100 cell divisions. In contrast, when auxotrophy complementation was employed, all cells analyzed retained the reporter plasmid (pSEVA117RbT or D, pSEVA177RbT or D). The previously used low-copy number RK2 origin control (pSEVA127Rb) was retained by approximately half of the population under the same conditions, while the high-copy pUC origin reporter plasmid (pSEVA167Rb) was lost from the population after ∼60 to 70 divisions, its presence likely placing an unfavorable burden on the host due to the energetic cost of its high replication rate.
While these two auxotrophy systems provide an antibiotic-free method of selecting for plasmids, their stability can easily be disturbed by the addition to the media of the relevant key metabolite (Figure 2c; thyA+ plasmids are lost more quickly than dapA+). This indicates the importance of choosing auxotrophies based on metabolites that are absent from the intended application environment. As an example, the performance of the ΔthyA and ΔdapA E. coli DIAL strains in garden soil was investigated. Soil was taken and used as a supplement for overnight cultures of auxotrophic medium-copy DIAL strains (EI) in SOB (Figure 2d). Both ΔthyA and ΔdapA strains grew poorly in nonsterile soil, with ΔdapA resulting in the fewest E. coli colonies. (Observation of larger, noncoliform colonies indicates the presence of additional kanamycin-resistant microbes in the soil used.) When supplemented with either the appropriate key metabolite or complementation plasmid (e.g., pSEVA177RbT or D), knockout strain growth density returned to wild-type levels. When sterile soil was used (Supporting Information Figure 1) in order to remove any potential competition effect that native microbes may have on key metabolite utilization, the ΔdapA strain still failed to thrive, implying that there is insufficient environmental DAP to support knockout growth. (24, 25) The growth of ΔthyA, however, was restored, indicating the presence of adequate thymidine nucleoside in the sterilized soil sample. Although this indicates potential for the eventual disruption of plasmid propagation, such imperfect retention may actually be preferred from a biosafety standpoint. Gradual plasmid loss, when combined with a host fitness deficit, should lead to GMMs that survive for months in the environment, rather than years. This is preferable for reducing the long-term chance of genetic pollution, and could theoretically be tuned for specific applications. For example, an auxotrophy based on an abundant environmental metabolite could be used with contained biosensors (e.g., those housed in a pregnancy-test-like device (2)), thereby ensuring a rapid loss of plasmid retention pressure in the event of GMM leakage.

Figure 2

Figure 2. Plasmid stability in auxotrophic strains. (a) Schematic of DIAL strain auxotroph (ΔthyA or ΔdapA) dependence on complementing plasmid (thyA+ or dapA+). Orange arrow indicates complementation of knocked-out gene (remnants represented by orange bars on chromosome). (b) Stability assay measuring the proportion of colonies that retain their plasmid in low-copy DIAL strain AB after ∼100 generations in liquid LB without antibiotic selection (n = 4 biological repeats; error bars = standard deviation). (c) Assay as above, but plated on agar containing key metabolite to assess plasmid stability when auxotrophic pressure is removed (n = 4 biological repeats; error bars = standard deviation). (d) Assessment nonsterile soil’s ability to provide key metabolite to auxotrophs when added to liquid SOB and incubated overnight (dilution series subsequently plated on kanamycin-containing LB agar to suppress growth of other soil microbes). kanR, kanamycin resistance cassette; dark purple bars, FRT (flippase recognition target); thyd., thymidine; DAP, diaminopimelic acid; KO, knockout; R6K (pSEVA117Rb), ColE2 (pSEVA177Rb), R6K-thyA (pSEVA117RbT), ColE2-thyA (pSEVA177RbT), R6K-dapA (pSEVA117RbD), ColE2-dapA (pSEVA177RbD), low RK2 (pSEVA127Rb), high pUC (pSEVA167Rb) (see Supporting Information Table 1 for more detail).

Toxin–Antitoxin Systems As a Negative Selection Pressure

A GMM that undergoes environmental deployment may contain synthetic genes that are advantageous for other organisms to acquire. To further reduce the likelihood of plasmid acquisition beyond a specified host, DNA-encoded broad-spectrum toxins were investigated as a means of exerting negative selection pressure on wild-type microbes. With plasmid-encoded toxins, host immunity is provided in trans via genomic integration of the cognate antitoxin. Full dependency on the expression or function of a toxin–antitoxin pair is a major flaw in previous “kill-switch” designs, as an inability to protect against inactivating mutations ultimately leads to safety system failure. (5, 26) In GeneGuard, a toxin–antitoxin pair is instead employed in an auxiliary manner, that is, continued function is not critical to the overall integrity of the system.
As toxin activity is required to be broad-spectrum to work against a variety of environmental microbes, a broad-host-range constitutive promoter was used to maximize the likelihood of expression, and the toxins ζ (from Streptococcus pyogenes plasmid pSM19035) (27, 28) and Kid (from E. coli plasmid R1) (29) were investigated. These proteins are reported to be growth-inhibitory (i.e., bacteriostatic) when expressed in Gram-positive, Gram-negative, and even some eukaryotic hosts. It is important to note that the term “toxin” relates to their activity as cytosolic enzymes: ζ interferes with the beginning of peptidoglycan synthesis, (30) while Kid is a sequence-specific endoribonuclease. (31) The poisoning of nearby organisms is therefore highly unlikely, as any released enzyme would require cellular internalization before toxicity could occur; its degradation is more probable.
His-tagged antitoxin genes for ε (27) or Kis (29) were paired with promoter P1 and ThrA-BCD2 (11) and genome-integrated as per previously (i.e., auxotrophs were also simultaneously created; Figure 3a). While integration fixes antitoxin gene copy number, plasmid-encoded toxin levels will vary depending on the host DIAL strain used. A balance is therefore required so that toxin gene dosage at a high plasmid copy number does not overwhelm the available antitoxin, while maintaining an adequate expression of toxin such that a low-copy dosage remains toxic to wild-type cells lacking the antidote. This was achieved through tuning toxin expression levels with a designed, E. coli and B. subtilis compatible, spoVG RBS (32) paired with a similarly compatible constitutive Pveg2 promoter. His-tagged ζ and Kid genes were inserted into the thyA/dapA complementation plasmids (containing the ColE2 COR) so that both the auxotrophy complementation and toxin open reading frames converged upon a bidirectional terminator flanked by synthetic insulating spacers. (33)
The use of spoVG2 gave tolerable levels of ζ in all antitoxin-expressing DIAL strains. Kid expression, however, required down-tuning for its plasmid to be acceptable to the high-copy DIAL strain JK (the spoVG5 promoter, at ∼27% of the strength (32) of spoVG2, was settled upon). Both the ζ and Kid plasmids (pSEVA177RbTZh or TKh, DZh, or DKh), when hosted by their respective antitoxin/auxotrophic DIAL strains (AB, EI, or JK), did not perturb the growth rate from that of the wild-type (Figure 3b; Supporting Information Figure 2). Expression of antitoxin was confirmed via Western blot (Figure 3c) with toxin expression only just visible for both types in the high-copy DIAL strain JK. The strong antitoxin bands observed indicate that greater expression of both toxins should be possible: ζ is neutralized by ε at a 1:1 ratio, (30) while two molecules of Kid are neutralized by each Kis. (34) Greater expression was not found to be possible for Kid, however, as demonstrated by the need to tune its translation down with spoVG5.
To confirm toxin activity in cells lacking antitoxin, the above plasmids were transformed into the low, medium and high-copy number auxotrophic DIAL strains that lacked the relevant antitoxin gene, and as intended, no colonies were immediately obtainable. After prolonged incubation for ∼72 h, however, thousands of small colonies appeared on low-copy DIAL strain AB plates hosting the Kid toxin. This possibly indicates insufficient Kid expression for complete bacteriostasis. In addition, when the selection pressure of auxotrophy complementation was removed through the use of prototrophic DIAL strains, several healthy colonies were obtained from each toxin plasmid transformation. This was due to deleterious recA-mediated homologous recombination between two similarly orientated pVeg promoters within our test plasmids, leading to toxin gene removal (pVeg also drove mRFP1 expression). This event was not seen in our auxotrophic DIAL strains, as such recombination also leads to the deletion of the essential complementation gene (see Figure 3a).
To assess toxin activity in a Gram-positive bacterium, toxin genes were transferred to a SEVA shuttle backbone containing a dual replication origin (pUC and pTHT15) and a chloramphenicol resistance cassette compatible for use in both E. coli and B. subtilis. (35) These constructs (pSEVA3b6Zh or Kh) contained no mRFP1 reporter, eliminating the previous source of recombination-mediated toxin deletion. To simulate a transformation that is more environmentally realistic than electroporation, a competence-inducible B. subtilis strain (SCK6 (12)) was used. While electroporation of E. coli DH10B gave no colonies for either the ζ or Kid toxin plasmids (Figure 3d), several ζ colonies and hundreds of Kid colonies resulted when transforming B. subtilis SCK6. The lack of Kid toxicity in B. subtilis SCK6 is likely due to the pre-existing genomic presence of a Kis antitoxin homologue, such as YdcD. (36) Taken together, the data presented reinforces the futility of relying on toxin integrity over time, and supports our approach of only utilizing kill-switch devices in an auxiliary role. Table 1 summarizes the ability of the described devices to influence plasmid propagation.

Figure 3

Figure 3. Use of ζ–ε and Kid-Kis toxin–antitoxin pairs. (a) Schematic of how a toxin-encoding plasmid may prove deleterious if taken up by wild-type cells, while the specified host cell possesses genome-encoded immunity. (b) Growth curves of high-copy DIAL strain JK with various combinations of ΔdapA auxotrophy, chromosomally integrated ε or Kis antitoxin, and plasmid-encoded ζ or Kid toxin (ColE2 COR used; n = 3 biological repeats; error bars = standard deviation). For ΔthyA auxotrophy, and other plasmid copy numbers, see Supporting Information Figure 2. (c) Western blot of various DIAL strains constitutively expressing integrated ε (11.5 kDa) or Kis (10.2 kDa) antitoxins alone, as well as with plasmid-encoded ζ (33.2 kDa) or Kid (12.7 kDa) toxins. All toxins/antitoxins are His-tagged at the C-terminus; putative toxin bands are arrowed. (d) Transformation assessment of ability of wild-type cells to maintain toxin plasmid in the absence of integrated antitoxin. W/T, wild-type; antiT, antitoxin; WM, weight marker; dapA (pSEVA177RbD); dapA-ζ (pSEVA177RbDZh); dapA-Kid (pSEVA177RbDKh); control plasmid (pSEVA3b61); ζ plasmid (pSEVA3b6Zh); Kid plasmid (pSEVA3b6Kh).

Table 1. Summary of COR, Auxotrophy Complementation and Toxin Device Effects on Host Cell Propagationa
 pSEVA3b61 ControlpSEVA117Rb R6K CORpSEVA177Rb ColE2 CORpSEVA3b6Zh ζ toxinpSEVA3b6Kh Kid toxinpSEVA177RbT ColE2 + thyApSEVA177RbD ColE2 + dapApSEVA177RbDZh ColE2 + dapA + ζpSEVA177RbDKh ColE2 + dapA + Kid
E. coli MC1061>1000 (n = 3)0 (n = 2)0 (n = 2)<10 (n = 2)<10 (n = 2)
E. coli DIALb>1000 (n = 2)>1000 (n = 3)>1000 (n = 3)<10 (n = 4)<10 (n = 2)>1000 (n = 2)>1000 (n = 2)<10 (n = 3)c<100 (n = 3)c
E. coli DIAL auxob>1000 (n = 5)>1000 (n = 5)0 (n = 6)0 (n = 6)
E. coli DIAL auxo/antitoxinb>1000 (n = 2)>1000 (n = 2)>1000 (n = 2)>1000 (n = 1)>1000 (n = 6)>1000 (n = 6)
B. subtilis SCK6>100 (n = 3)0 (n = 2)d<10 (n = 2)d<10 (n = 3)>100 (n = 3)
a

Approximate number of colonies resulting from transformation of plasmid containing the various devices into each cell line.

b

Low, medium or high plasmid copy number DIAL strains gave similar results for each plasmid (strains with cognate auxotrophies/antitoxins used where appropriate).

c

Homologous recombination led to deletion of toxin gene.

d

pSEVA3b17Rb or pSEVA3b77Rb used respectively for testing R6K or ColE2 in B. subtilis due to antibiotic resistance cassette compatibility. Dashes indicate experiment not performed as considered unnecessary. For full plasmid and strain details, see Supporting Information Table 1.

GeneGuard Genomic and Vector Cassettes

Following assessment of the individual devices, various COR, auxotrophy, and toxin–antitoxin combinations were arranged into a complete GeneGuard system (Figure 4). A genomic integration cassette was designed to serve as a PCR template for the λ Red-mediated genomic insertion method, and consists of genes for the COR replication initiator, an antitoxin and a kanamycin selection cassette, all flanked by the necessary 5′ and 3′ homology arms for thyA or dapA knockout creation. A low-copy RK2 origin is used in this plasmid to minimize gene dosage problems (excess antitoxin production was itself found to exhibit toxicity), and a constitutive mRFP1 marker allows for easy identification of false-positives during the integration procedure (i.e., template plasmid carryover). Once a knockout is verified, P1 transduction can be performed if desired, and the FRT-flanked kanamycin selection cassette may be excised using the pCP20-encoded FLP recombinase. (21) Note that the kanamycin resistance gene is not strictly necessary when integrating at thyA, as trimethoprim may instead be used as a counter-selection agent. (19)
The accompanying vector cassette consists of a COR region and toxin and auxotrophy complementation genes. With a total size of ∼2.7 kbp, this compact cassette may be directly amplified by PCR and used to simultaneously replace the replication origin and resistance gene of a pre-existing plasmid (i.e., retrofitting) or the vector cassette itself can be used as a readymade plasmid backbone for the insertion of cargo DNA. To ease initial plasmid manipulation in standard cloning strains, a removable antibiotic resistance cassette is also included in the multicloning site of the vector cassette backbone.

Figure 4

Figure 4. Schematic of the GeneGuard system. The genomic cassette (a) consists of replication initiator, antitoxin and FRT-bound kanamycin resistance genes, flanked by ∼280 to 500 bp of 5′/3′ UTR sequence from the thyA or dapA genes (total cassette size of ∼3.6–3.8 kbp). The vector cassette (b) hosts cargo DNA via a pUC18-derived multicloning site that contains a removable antibiotic resistance gene between the PacI and AvrII sites. To retrofit existing plasmids, the COR/toxin/auxotrophy cassette (c) may be PCR-amplified and swapped with the existing origin/antibiotic resistance region. After construction, GeneGuard-derived plasmids are dependent on host cells that contain the requisite genomic cassette (d).

Using the GeneGuard System for Heavy-Metal Biosensors

The GeneGuard system must satisfy two criteria for use in environmental synthetic biology applications: (i) it must increase biosafety but (ii) not disrupt application functionality. To demonstrate that our plasmids fit the second criterion, we took previously described arsenic, mercury, and copper biosensors (37) and compared their performance when hosted on their original backbone to that of two different medium-copy GeneGuard plasmids (Figure 5). When the pD1K backbone (dapA+, R6K COR, Kid toxin) is used, fluorescence output at all heavy-metal concentrations is beneficially elevated in comparison to the original medium-copy number pSB3K3 BioBrick plasmid. When pT7Z (thyA+, ColE2 COR, ζ toxin) is used, the biosensors have a dose response profile more equivalent to that of the original pSB3K3 backbone. This proves that the GeneGuard system does not hamper cargo function, and hence that it could be used for real-world deployment.
The useful but unexpected increase in dynamic signal range for pD1K-hosted biosensors (see Supporting Information Figure 3) is likely due to greater than expected π replication initiator production, resulting in a higher than desired plasmid copy number. This illustrates the importance of the genomic cassette’s architecture: whereas in the original DIAL strains the replication initiator genes were placed in disparate genomic regions, here they were inserted immediately downstream of the native thyA or dapA promoter region and may therefore suffer from transcriptional read-through. Inversion of the replication initiator gene in a future iteration of the GeneGuard genomic cassette would address this.
Our GeneGuard system, while simple in concept, is sturdier in design when compared to other complicated biosecurity solutions. (38, 39) Through the use of three distinct mechanisms, it has redundancy in its design and is highly unlikely to provide any benefit to wild-type cells, therefore limiting the potential for genetic pollution. A COR sequence on its own is of little use, unless receiving microbes already host similar initiator-encoding plasmids (and even then plasmid incompatibility will likely result). The acquisition of a constitutive auxotrophy complementation gene also provides little utility; it may lead to greater flux through a pathway, but as thymidine and DAP biosynthesis genes are already pervasive, this is unlikely to confer a significant benefit. The toxins have been selected specifically to produce a negative selection pressure, and even if their activity is neutralized via mutation or through the presence of a pre-existing antitoxin, no evolutionary advantage will ensue. While this version of GeneGuard is designed to work in E. coli, application to other environmentally relevant bacteria is possible. For example, thymidine and DAP auxotrophies have been experimented with in Pseudomonas fluorescens (24, 25) and P. putida (40) for bioremediation roles, while B. subtilis required the deletion of two discontiguous thymidylate synthetase genes to create a thymidine auxotroph. (41) It is important to note, however, that each species requires context-specific optimization of GeneGuard device expression and function, a nontrivial task if plasmid construction and propagation during this optimization relies on using E. coli cloning strains.
GeneGuard, as presented here, represents the state-of-the-art for E. coli plasmid biosecurity. In our opinion, the best combination of parts profiled would be the ColE2 COR combined with ΔdapA complementation (soil lacks sufficient DAP) and the ζ toxin (effective against E. coli and B. subtilis). Our system could further be improved to limit successful HGT by refactoring vector parts to have minimal homology to all known microbial genomes (e.g., codon shuffling of the auxotrophy complementation genes) or plasmids, and through the future addition of alternative parts into the modular set. In addition, integration of the replication initiator and antitoxin genes at different genomic loci would further decrease the chance of both parts transposing to, or with, the synthetic plasmid into other cells. This, however, would require additional genomic manipulation. In conclusion, adoption of GeneGuard for environmental synthetic biology would be a beneficial move, as common biosafety concerns can be addressed without detriment to end-use applications. Whether this satisfies local and/or supranational regulations, however, is an ongoing debate. A recent workshop (42) held on this subject, covering past examples and current regulatory issues, discusses and summarizes the prospects and hurdles faced for future deployment requests of GMMs.

Figure 5

Figure 5. GeneGuard system applied to heavy-metal biosensors. (a) Schematic of biosensors inserted into GeneGuard plasmids. Arsenic relieves ArsR repression of ParsR; mercury relieves MerR repression of PmerT; and copper enables CusR activation of PcusC. Each of these promoters is linked to the reporter GFPmut3b. (b) Dose response curves in E. coli DH10B for the arsenic biosensor in its original plasmid (pSB3K3 contains a medium-copy p15A origin, requires kanamycin selection), and its performance when ported to GeneGuard variants pD1K (dapA, R6K COR, Kid toxin; no antibiotic selection used) and pT7Z (thyA, ColE2 COR, ζ toxin; no antibiotic selection used) with the requisite genomic cassettes inserted to support a medium-copy plasmid number (n = 4 biological repeats; error bars = standard deviation). (c) Dose response curves for the mercury biosensor, as per part b. (d) Dose response curves for the copper biosensor, as per part b. W/T, wild-type; au, arbitrary units; WHO, World Health Organization. (43) For low and high-copy GeneGuard plasmid results, see Supporting Information Figure 3.

Methods

ARTICLE SECTIONS
Jump To

Media and General Materials

Microbes were propagated in LB broth/agar, supplemented as appropriate with thymidine (20 mg/mL stock prepared in water) or diaminopimelic acid (DAP; 20 mg/mL stock prepared in water, with 10 M NaOH added dropwise until solute dissolved) to a final concentration of 50 μg/mL. (44-46) (Thymine, despite a previous report, (19) was unable to support ΔthyA cells.) Ampicillin was used at 100 μg/mL; kanamycin at 25 μg/mL; and chloramphenicol at 6 μg/mL. Sterile polystyrene 96-well plates from Corning B.V. Life Sciences were used for all assays, and sealed with Breathe-Easy sealing membrane (Sigma-Aldrich Company Ltd.) prior to any incubation step. B. subtilis SCK6 (12) was purchased from the Bacillus Genetic Stock Center (http://www.bgsc.org/).

Device Construction

Oligos were ordered from Integrated DNA Technologies BVBA, and larger DNA pieces as GeneArt Strings from Life Technologies Ltd. Phusion High-Fidelity DNA polymerase (20 μL reactions; New England Biolabs (U.K.) Ltd.) was used according to the manufacturer’s instructions for part construction, along with touchdown PCR (47) and overlap extension PCR (48) for device assembly/point mutations (for full sequence details and GenBank accession numbers, see Supporting Information Table 1). For colony PCR, REDTaq ReadyMix (10 μL reactions; Sigma-Aldrich Company Ltd.) was used according to the manufacturer’s instructions on colony scrapings from sterile toothpicks. Sequence verification was performed by Source BioScience Plc.

Flow Cytometry

Using 96-well plates, 2 μL of overnight culture was used to seed 200 μL of fresh LB (with ampicillin) and incubated to mid log phase (30 °C, ∼710 rpm, for ∼3 h). After dilution in water, samples were analyzed using a FACScan (Becton Dickinson Co.) that had been upgraded by Cytek Development Inc. and coupled to an Automated Machine Sampler system (Cytek Development Inc.). Excitation of mRFP1 was at 561 nm, with emission monitored at 615/25 nm. Data was collected using CellQuest Pro (v5.1.1; Becton Dickinson Co.), and processed using FlowJo (v7.6.5; Tree Star Inc.).

Genomic Integration

Genomic integration was performed as previously described. (21) For each reaction, 166 μL overnight culture of desired host strain (pretransformed with pKD46; encodes arabinose-inducible λ Red recombinase system) was used to seed 8.3 mL LB (1/50 dilution; ampicillin) and grown at 30 °C, ∼225 rpm, for 1 h. Arabinose was then added to 0.05% (∼3.3 mM; 20% stock), and incubation continued until OD600 ≈ 0.4. After washing and concentrating cells to 50 μL in 20% glycerol, 200 to 400 ng of PCR product to be inserted (amplified from ∼100 pg template plasmid; purified, resuspended in water) was added for electroporation. Transformed cells were recovered for 2 h at 37 °C, ∼225 rpm, pelleted and plated on LB agar (with kanamycin, plus key metabolite to supplement the introduced auxotrophy), and incubated overnight at 37 °C. Typically ∼50 to 500 colonies were obtained, the large majority of which were successful integrants. It is worth noting that the integration of the PCR products (∼3.8 kbp) used in this work is pushing the known limits of the λ Red method. (49) In addition, thiamine pyrophosphate (50) knockouts (TPP; ΔthiL) were also attempted (TPP supplemented to 4.6 μg/mL (51, 52)), but for unknown reasons, we were unable to isolate an auxotroph.

Plasmid Stability Assay

Using 96-well plates, 0.2 μL of overnight culture under antibiotic selection pressure (ampicillin) was used to seed 200 μL of fresh LB (no antibiotic) and incubated at 37 °C, ∼850 rpm, for ∼6 h to achieve culture saturation (approximately 10 generations). Passaging was repeated until ∼100 generations were achieved, at which point 20 μL of a 1 × 10–5 dilution was added to 50 μL fresh LB and plated on LB agar with or without antibiotic. Resultant colonies (from the nonselective plates) were examined for the presence of mRFP1 fluorescence as an indicator of plasmid retention using a hand-held 532 nm laser pointer in combination with the bandpass emission filter of a Visi-Blue transilluminator (Ultra-Violet Products Ltd.). For ColE2 CORs, where fluorescence in the low-copy DIAL strain AB was too faint to reliably assess, a combination of colony PCR, streak testing on selective media, and comparison of colony numbers on selective/nonselective media were instead made.

Soil Assay

One g of fresh or autoclaved garden soil (London, postcode SW10 0QP) was added to 3 mL of SOB medium (no antibiotic) and inoculated with 1 μL of overnight culture (grown in the presence of supplement where necessary). Cultures were grown overnight in 15 mL tubes at 30 °C, ∼225 rpm, and soil allowed to sediment before serial dilutions (1 × 10–2 to 1 × 10–7) were made using a 96-well plate (final volumes of 180 μL). Each dilution (10 μL) was dropped onto LB agar containing kanamycin to select for auxotrophic E. coli strain growth, allowed to dry, and incubated overnight at 30 °C. Only ColE2 CORs in medium copy (EI) DIAL strain auxotrophs were assessed; the wild-type control (i.e., prototroph) harbored an intermediary construction plasmid containing a R6K COR and kanR cassette.

Growth Curves

0.2 μL of overnight culture was diluted 1/9000 in 1.8 mL LB (∼5 × 104 colony forming units/mL (53)), with 200 μL subsequently aliquoted into a 96-well plate. Experiments were performed in situ using a POLARstar Omega microplate reader (BMG Labtech GMBH), at 37 °C, ∼700 rpm, with OD600 read every 30 min. Data was collected using Omega (v1.02) and MARS Data Analysis software (v1.10; BMG Labtech GMBH), and growth curves manually shifted along the X-axis to compensate for any initial lag phase.

Western Blotting

500 μL aliquots of mid log phase cultures (1/100 overnight culture dilution, grown for 3 h at 37 °C, ∼225 rpm) were pelleted and resuspended in sufficient Laemmli sample buffer (54) to normalize OD600 to 0.4 (in an assumed 50 μL volume), boiled for ∼2 min and then allowed to cool. For ζ-His/ε-His, 7 μL of prepared sample was loaded onto an Any kD Mini-PROTEAN TGX precast gel (Bio-Rad Laboratories Ltd.); for fainter Kid-His/Kis-His samples, 14 μL was used. The gel was run in a Mini-PROTEAN Tetra Cell (Bio-Rad Laboratories Ltd.) with 5 μL of PageRuler Prestained Protein Ladder (Fisher Scientific U.K. Ltd.), transferred to a PVDF membrane using a Trans-Blot SD Semi-Dry Electrophoretic Transfer Cell (Bio-Rad Laboratories Ltd.), and visualized with a WesternBreeze chromogenic immunodetection kit using Novex histidine tag (6×His) monoclonal mouse antibody (Life Technologies Ltd.) as the primary antibody at a concentration of 0.33 μg/mL (1/1500 dilution) (all as per the manufacturer’s instructions).

Transformation Assay

For E. coli strains, 1 μL of 50 ng/μL plasmid stock was electroporated (1.8 kV, 0.1 cm electrocuvettes) into 50 μL aliquots of prepared cells (harvested mid log phase, washed and concentrated ∼133x in 20% glycerol, stored at −80 °C) using a MicroPulser electroporator (Bio-Rad Laboratories Ltd.) as per the manufacturer’s instructions, and recovered in 300 μL of LB for 1 h at 37 °C, ∼225 rpm. 100 μL was then plated on selective LB agar. For B. subtilis SCK6 (integrated PxylA-comK (12)), 1 mL of overnight culture was diluted with 2 mL fresh LB, and 105 μL of filter-sterilized 30% d-xylose added to induce competence (1% final conc.). After 2 h at 37 °C, ∼225 rpm, 100 μL aliquots were taken, 5 μL of 20 ng/μL plasmid added and incubation continued for 90 min, after which all was plated on LB agar (with chloramphenicol). All plates were incubated overnight at 37 °C.

Biosensor Assay

Overnight culture (15 μL) was diluted 1/100 in 1.5 mL LB, with 180 μL subsequently added to wells containing 20 μL of serially diluted heavy-metal (32 μM to 0.5 μM Na2HAsO4; 6 to 0.5 μM HgCl2; 2,000 to 31 μM CuSO4) in a 96-well plate, mixing well. Sealed plates were incubated at 30 °C, ∼710 rpm, for 6 h prior to OD600 and GFPmut3b fluorescence (485 nm excitation, 520 nm emission, with the gain set to 1000 and bottom reading optics used) being read on a POLARstar Omega microplate reader (BMG Labtech GMBH; see previous). Antibiotic (kanamycin) was only present in samples containing the original pSB3K3 plasmids.

Supporting Information

ARTICLE SECTIONS
Jump To

Supplementary figures, sequence tables, GenBank accession numbers, and annotated plasmid ApE files (ApE can be downloaded for free at http://biologylabs.utah.edu/jorgensen/wayned/ape/). This material is available free of charge via the Internet at http://pubs.acs.org. In addition, selected GeneGuard plasmids may be obtained from the SEVA repository by request (see http://seva.cnb.csic.es/).

Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Author Information

ARTICLE SECTIONS
Jump To

  • Corresponding Author
    • Tom Ellis - Centre for Synthetic Biology and Innovation, Imperial College London, London SW7 2AZ, United KingdomDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom Email: [email protected]
  • Authors
    • Oliver Wright - Centre for Synthetic Biology and Innovation, Imperial College London, London SW7 2AZ, United KingdomDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom
    • Mihails Delmans - Centre for Synthetic Biology and Innovation, Imperial College London, London SW7 2AZ, United KingdomDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom
    • Guy-Bart Stan - Centre for Synthetic Biology and Innovation, Imperial College London, London SW7 2AZ, United KingdomDepartment of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom
  • Funding

    This work was supported by a grant awarded through the Biotechnology and Biological Sciences Research Council (BBSRC)/Defence Science and Technology Laboratory (DSTL)/Engineering and Physical Sciences Research Council (EPSRC)/Medical Research Council (MRC) Joint Synthetic Biology Initiative (BB/J019720/1). G.B.S. and T.E. are further supported by EPSRC Science and Innovation Award EP/G036004/1.

  • Notes
    The authors declare no competing financial interest.

Acknowledgment

ARTICLE SECTIONS
Jump To

We wish to thank the Imperial College 2011 iGEM team “Auxin” for their initial work and ideas on a prototype GeneGuard system, and Richard Thomas (DSTL) for his comments throughout this research project. We also thank Prof J. Christopher Anderson (Dept of Bioengineering, University of California, Berkeley) for the gift of the DIAL strains and pBjk2992_jtk2828; (15) Prof Víctor de Lorenzo (Systems Biology Program, Centro Nacional de Biotecnología, Madrid) for the gift of SEVA plasmids; (10) Dr. Urszula Zielenkiewicz (Dept of Microbial Biochemistry, Institute of Biochemistry and Biophysics of the Polish Academy of Sciences) for the gift of pBT286; (27) Prof. Ramón Díaz-Orejas (Dept of Molecular Microbiology and Infection Biology, Centro de Investigaciones Biológicas, Madrid) for the gift of pAB24; (55) and Dr. Baojun Wang (School of Biological Sciences, University of Edinburgh) for the gift of pSB3K3-Ars (aka pSB3K3-ParsR-rbs30-gfp), pSB3K3-Mer (aka pSB3K3-PmerT-rbs32-gfp), and pSB3K3-Cus (aka pSB3K3-PcusC-rbs31-gfp). (37)

References

ARTICLE SECTIONS
Jump To

This article references 55 other publications.

  1. 1
    Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., and Keasling, J. D. (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids Nat. Biotechnol. 21, 796 802
  2. 2
    French, C. E., de Mora, K., Joshi, N., Elfick, A., Haseloff, J., and Ajioka, J. (2011) Synthetic biology and the art of biosensor design. In The Science and Applications of Synthetic and Systems Biology: Workshop Summary, pp 178 201, National Academies Press, Washington DC; NCBI bookshelf ID NBK84465.
  3. 3
    Singh, J. S., Abhilash, P. C., Singh, H. B., Singh, R. P., and Singh, D. P. (2011) Genetically engineered bacteria: An emerging tool for environmental remediation and future research perspectives Gene 480, 1 9
  4. 4
    Brune, K. D. and Bayer, T. S. (2012) Engineering microbial consortia to enhance biomining and bioremediation Front. Microbiol. 3, 203
  5. 5
    Moe-Behrens, G. H. G., Davis, R., and Haynes, K. A. (2013) Preparing synthetic biology for the world Front. Microbiol. 4, 5
  6. 6
    Wright, O., Stan, G.-B., and Ellis, T. (2013) Building-in biosafety for synthetic biology Microbiology 159, 1221 1235
  7. 7
    Lajoie, M. J., Rovner, A. J., Goodman, D. B., Aerni, H. R., Haimovich, A. D., Kuznetsov, G., Mercer, J. A., Wang, H. H., Carr, P. A., Mosberg, J. A., Rohland, N., Schultz, P. G., Jacobson, J. M., Rinehart, J., Church, G. M., and Isaacs, F. J. (2013) Genomically recoded organisms expand biological functions Science 342, 357 360
  8. 8
    Schmidt, M. (2010) Xenobiology: A new form of life as the ultimate biosafety tool Bioessays 32, 322 331
  9. 9
    Benner, S. A. and Sismour, A. M. (2005) Synthetic biology Nat. Rev. Genet. 6, 533 543
  10. 10
    Silva-Rocha, R., Martínez-García, E., Calles, B., Chavarría, M., Arce-Rodríguez, A., Las de Heras, A., Páez-Espino, A. D., Durante-Rodríguez, G., Kim, J., Nikel, P. I., Platero, R., and de Lorenzo, V. (2012) The Standard European Vector Architecture (SEVA): A coherent platform for the analysis and deployment of complex prokaryotic phenotypes Nucleic Acids Res. 41, D666 D675
  11. 11
    Mutalik, V. K., Guimaraes, J. C., Cambray, G., Lam, C., Christoffersen, M. J., Mai, Q.-A., Tran, A. B., Paull, M., Keasling, J. D., Arkin, A. P., and Endy, D. (2013) Precise and reliable gene expression via standard transcription and translation initiation elements Nat. Methods 10, 354 360
  12. 12
    Zhang, X.-Z. and Zhang, Y. H. P. (2011) Simple, fast and high-efficiency transformation system for directed evolution of cellulase in Bacillus subtilis Microb. Biotechnol. 4, 98 105
  13. 13
    Filutowicz, M., McEachern, M. J., and Helinski, D. R. (1986) Positive and negative roles of an initiator protein at an origin of replication Proc. Natl. Acad. Sci. U.S.A. 83, 9645 9649
  14. 14
    Hiraga, S., Sugiyama, T., and Itoh, T. (1994) Comparative analysis of the replicon regions of eleven ColE2-related plasmids J. Bacteriol. 176, 7233 7243
  15. 15
    Kittleson, J. T., Cheung, S., and Anderson, J. C. (2011) Rapid optimization of gene dosage in E. coli using DIAL strains J. Biol. Eng. 5, 10
  16. 16
    Durland, R. H. and Helinski, D. R. (1990) Replication of the broad-host-range plasmid RK2: Direct measurement of intracellular concentrations of the essential TrfA replication proteins and their effect on plasmid copy number J. Bacteriol. 172, 3849 3858
  17. 17
    Miki, T., Yasukochi, T., Nagatani, H., Furuno, M., Orita, T., Yamada, H., Imoto, T., and Horiuchi, T. (1987) Construction of a plasmid vector for the regulatable high level expression of eukaryotic genes in Escherichia coli: An application to overproduction of chicken lysozyme Protein Eng. 1, 327 332
  18. 18
    Lin-Chao, S., Chen, W.-T., and Wong, T.-T. (1992) High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II Mol. Microbiol. 6, 3385 3393
  19. 19
    Wong, Q. N. Y., Ng, V. C. W., Lin, M. C. M., Kung, H.-F., Chan, D., and Huang, J.-D. (2005) Efficient and seamless DNA recombineering using a thymidylate synthase A selection system in Escherichia coli Nucleic Acids Res. 33, e59
  20. 20
    Acord, J. and Masters, M. (2004) Expression from the Escherichia coli dapA promoter is regulated by intracellular levels of diaminopimelic acid FEMS Microbiol. Lett. 235, 131 137
  21. 21
    Datsenko, K. A. and Wanner, B. L. (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products Proc. Natl. Acad. Sci. U.S.A. 97, 6640 6645
  22. 22
    Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., and Mori, H. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: The Keio collection Mol. Syst. Biol. 2, 0008
  23. 23
    Shetty, R. P., Endy, D., and Knight, T. F. (2008) Engineering BioBrick vectors from BioBrick parts J. Biol. Eng. 2, 5
  24. 24
    Silby, M. W. and Levy, S. B. (2004) Use of in vivo expression technology to identify genes important in growth and survival of Pseudomonas fluorescens Pf0-1 in soil: Discovery of expressed sequences with novel genetic organization J. Bacteriol. 186, 7411 7419
  25. 25
    Varivarn, K., Champa, L. A., Silby, M. W., and Robleto, E. A. (2013) Colonization strategies of Pseudomonas fluorescens Pf0-1: Activation of soil-specific genes important for diverse and specific environments BMC Microbiol. 13, 92
  26. 26
    Molin, S., Boe, L., Jensen, L. B., Kristensen, C. S., Givskov, M., Ramos, J. L., and Bej, A. K. (1993) Suicidal genetic elements and their use in biological containment of bacteria Annu. Rev. Microbiol. 47, 139 166
  27. 27
    Zielenkiewicz, U. and Ceglowski, P. (2005) The toxin–antitoxin system of the streptococcal plasmid pSM19035 J. Bacteriol. 187, 6094 6105
  28. 28
    Zielenkiewicz, U., Kowalewska, M., Kaczor, C., and Ceglowski, P. (2009) In vivo interactions between toxin–antitoxin proteins epsilon and zeta of streptococcal plasmid pSM19035 in Saccharomyces cerevisiae J. Bacteriol. 191, 3677 3684
  29. 29
    de la Cueva-Méndez, G., Mills, A. D., Clay-Farrace, L., Díaz-Orejas, R., and Laskey, R. A. (2003) Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis EMBO J. 22, 246 251
  30. 30
    Mutschler, H., Gebhardt, M., Shoeman, R. L., and Meinhart, A. (2011) A novel mechanism of programmed cell death in bacteria by toxin–antitoxin systems corrupts peptidoglycan synthesis PLoS Biol. 9, e1001033
  31. 31
    Pimentel, B., Madine, M. A., and de la Cueva-Méndez, G. (2005) Kid cleaves specific mRNAs at UUACU sites to rescue the copy number of plasmid R1 EMBO J. 24, 3459 3469
  32. 32
    Salis, H. M., Mirsky, E. A., and Voigt, C. A. (2009) Automated design of synthetic ribosome binding sites to control protein expression Nat. Biotechnol. 27, 946 950
  33. 33
    Casini, A., MacDonald, J. T., Jonghe, J. D., Christodoulou, G., Freemont, P. S., Baldwin, G. S., and Ellis, T. (2013) One-pot DNA construction for synthetic biology: The Modular Overlap-Directed Assembly with Linkers (MODAL) strategy Nucleic Acids Res. 42, e7
  34. 34
    de la Cueva-Méndez, G. and Pimentel, B. (2007) Gene and cell survival: Lessons from prokaryotic plasmid R1 EMBO Rep. 8, 458 464
  35. 35
    Olson, D. G. and Lynd, L. R. (2012) Computational design and characterization of a temperature-sensitive plasmid replicon for gram positive thermophiles J. Biol. Eng. 6, 5
  36. 36
    Pellegrini, O., Mathy, N., Gogos, A., Shapiro, L., and Condon, C. (2005) The Bacillus subtilis ydcDE operon encodes an endoribonuclease of the MazF/PemK family and its inhibitor Mol. Microbiol. 56, 1139 1148
  37. 37
    Wang, B., Barahona, M., and Buck, M. (2013) A modular cell-based biosensor using engineered genetic logic circuits to detect and integrate multiple environmental signals Biosens. Bioelectron. 40, 368 376
  38. 38
    Friedland, A. E., Lu, T. K., Wang, X., Shi, D., Church, G., and Collins, J. J. (2009) Synthetic gene networks that count Science 324, 1199 1202
  39. 39
    Callura, J. M., Dwyer, D. J., Isaacs, F. J., Cantor, C. R., and Collins, J. J. (2010) Tracking, tuning, and terminating microbial physiology using synthetic riboregulators Proc. Natl. Acad. Sci. U.S.A. 107, 15898 15903
  40. 40
    Ronchel, M. C. and Ramos, J. L. (2001) Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation Appl. Environ. Microbiol. 67, 2649 2656
  41. 41
    Neuhard, J., Price, A. R., Schack, L., and Thomassen, E. (1978) Two thymidylate synthetases in Bacillus subtilis Proc. Natl. Acad. Sci. U.S.A. 75, 1194 1198
  42. 42
    Marris, C. and Jefferson, C. (2013) Synthetic Biology: Containment and Release of Engineered Micro-organisms. Workshop held at King’s College London, 29th April 2013. Summary of discussions available from http://www.kcl.ac.uk/sspp/departments/sshm/research/Research-Labs/CSynBi-Events.aspx.
  43. 43
    World Health Organization. ( (2011) Guidelines for Drinking-Water Quality, 4th ed., WHO Press, Geneva. Available from http://www.who.int/.
  44. 44
    Kang, H. Y., Dozois, C. M., Tinge, S. A., Lee, T. H., and Curtiss, R., III (2002) Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors J. Bacteriol. 184, 307 312
  45. 45
    Sat, B., Reches, M., and Engelberg-Kulka, H. (2003) The Escherichia coli mazEF suicide module mediates thymineless death J. Bacteriol. 185, 1803 1807
  46. 46
    Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., and Remaut, E. (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 Nat. Biotechnol. 21, 785 789
  47. 47
    Don, R. H., Cox, P. T., Wainwright, B. J., Baker, K., and Mattick, J. S. (1991) Touchdown PCR to circumvent spurious priming during gene amplification Nucleic Acids Res. 19, 4008
  48. 48
    Stemmer, W. P., Crameri, A., Ha, K. D., Brennan, T. M., and Heyneker, H. L. (1995) Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides Gene 164, 49 53
  49. 49
    Kuhlman, T. E. and Cox, E. C. (2010) Site-specific chromosomal integration of large synthetic constructs Nucleic Acids Res. 38, e92
  50. 50
    Imamura, N. and Nakayama, H. (1982) thiK and thiL loci of Escherichia coli J. Bacteriol. 151, 708 717
  51. 51
    Webb, E. and Downs, D. (1997) Characterization of thiL, encoding thiamin-monophosphate kinase Salmonella typhimurium J. Biol. Chem. 272, 15702 15707
  52. 52
    Schyns, G., Potot, S., Geng, Y., Barbosa, T. M., Henriques, A., and Perkins, J. B. (2005) Isolation and characterization of new thiamine-deregulated mutants of Bacillus subtilis J. Bacteriol. 187, 8127 8136
  53. 53
    Domínguez, M. C., La Rosa, de M., and Borobio, M. V. (2001) Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar J. Antimicrob. Chemother. 47, 391 398
  54. 54
    Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227, 680 685
  55. 55
    Bravo, A., Torrontegui, G., and Díaz, R. (1987) Identification of components of a new stability system of plasmid R1, ParD, that is close to the origin of replication of this plasmid Mol. Gen. Genet. 210, 101 110

Cited By

This article is cited by 80 publications.

  1. Swetha Sridhar, Caroline M. Ajo-Franklin, Caroline A. Masiello. A Framework for the Systematic Selection of Biosensor Chassis for Environmental Synthetic Biology. ACS Synthetic Biology 2022, 11 (9) , 2909-2916. https://doi.org/10.1021/acssynbio.2c00079
  2. Rudy Rubini, Clemens Mayer. Addicting Escherichia coli to New-to-Nature Reactions. ACS Chemical Biology 2020, 15 (12) , 3093-3098. https://doi.org/10.1021/acschembio.0c00713
  3. Tomoshige Fujino, Masahiro Tozaki, Hiroshi Murakami. An Amino Acid-Swapped Genetic Code. ACS Synthetic Biology 2020, 9 (10) , 2703-2713. https://doi.org/10.1021/acssynbio.0c00196
  4. Kei Motomura, Kosuke Sano, Satoru Watanabe, Akihiro Kanbara, Abdel-Hady Gamal Nasser, Takeshi Ikeda, Takenori Ishida, Hisakage Funabashi, Akio Kuroda, Ryuichi Hirota. Synthetic Phosphorus Metabolic Pathway for Biosafety and Contamination Management of Cyanobacterial Cultivation. ACS Synthetic Biology 2018, 7 (9) , 2189-2198. https://doi.org/10.1021/acssynbio.8b00199
  5. Ana Zúñiga, Francisco de la Fuente, Fernán Federici, Corinne Lionne, Jérome Bônnet, Victor de Lorenzo, Bernardo González. An Engineered Device for Indoleacetic Acid Production under Quorum Sensing Signals Enables Cupriavidus pinatubonensis JMP134 To Stimulate Plant Growth. ACS Synthetic Biology 2018, 7 (6) , 1519-1527. https://doi.org/10.1021/acssynbio.8b00002
  6. Francesca Volpetti, Ekaterina Petrova, and Sebastian J. Maerkl . A Microfluidic Biodisplay. ACS Synthetic Biology 2017, 6 (11) , 1979-1987. https://doi.org/10.1021/acssynbio.7b00088
  7. Bin Jia, Hao Qi, Bing-Zhi Li, Shuo Pan, Duo Liu, Hong Liu, Yizhi Cai, and Ying-Jin Yuan . Orthogonal Ribosome Biofirewall. ACS Synthetic Biology 2017, 6 (11) , 2108-2117. https://doi.org/10.1021/acssynbio.7b00148
  8. Haseong Kim, Eugene Rha, Wonjae Seong, Soo-Jin Yeom, Dae-Hee Lee, and Seung-Goo Lee . A Cell–Cell Communication-Based Screening System for Novel Microbes with Target Enzyme Activities. ACS Synthetic Biology 2016, 5 (11) , 1231-1238. https://doi.org/10.1021/acssynbio.5b00287
  9. Angel Goñi-Moreno, Marta Carcajona, Juhyun Kim, Esteban Martínez-García, Martyn Amos, and Víctor de Lorenzo . An Implementation-Focused Bio/Algorithmic Workflow for Synthetic Biology. ACS Synthetic Biology 2016, 5 (10) , 1127-1135. https://doi.org/10.1021/acssynbio.6b00029
  10. Andrés Arboleda-García, Ivan Alarcon-Ruiz, Lissette Boada-Acosta, Yadira Boada, Alejandro Vignoni, Eloisa Jantus-Lewintre. Advancements in synthetic biology-based bacterial cancer therapy: A modular design approach. Critical Reviews in Oncology/Hematology 2023, 190 , 104088. https://doi.org/10.1016/j.critrevonc.2023.104088
  11. Marc Blanch‐Asensio, Sourik Dey, Varun Sai Tadimarri, Shrikrishnan Sankaran. Expanding the genetic programmability of Lactiplantibacillus plantarum. Microbial Biotechnology 2023, 9 https://doi.org/10.1111/1751-7915.14335
  12. Jennifer L Chlebek, Sean P Leonard, Christina Kang-Yun, Mimi C Yung, Dante P Ricci, Yongqin Jiao, Dan M Park. Prolonging genetic circuit stability through adaptive evolution of overlapping genes. Nucleic Acids Research 2023, 51 (13) , 7094-7108. https://doi.org/10.1093/nar/gkad484
  13. Jiawei Wang, Debadyuti Ghosh, Mohammed Maniruzzaman. Using bugs as drugs: Administration of bacteria-related microbes to fight cancer. Advanced Drug Delivery Reviews 2023, 197 , 114825. https://doi.org/10.1016/j.addr.2023.114825
  14. Xueying Zhu, Zhaoyang Zhang, Bin Jia, Yingjin Yuan. Current advances of biocontainment strategy in synthetic biology. Chinese Journal of Chemical Engineering 2023, 56 , 141-151. https://doi.org/10.1016/j.cjche.2022.07.019
  15. Guilherme Pavão, Isabela Sfalcin, Diego Bonatto. Biocontainment Techniques and Applications for Yeast Biotechnology. Fermentation 2023, 9 (4) , 341. https://doi.org/10.3390/fermentation9040341
  16. Stefan A. Hoffmann, James Diggans, Douglas Densmore, Junbiao Dai, Tom Knight, Emily Leproust, Jef D. Boeke, Nicole Wheeler, Yizhi Cai. Safety by design: Biosafety and biosecurity in the age of synthetic genomics. iScience 2023, 26 (3) , 106165. https://doi.org/10.1016/j.isci.2023.106165
  17. Mohammed S Almuhayawi, Hattan S Gattan, Mohammed H Alruhaili, Mohanned Talal Alharbi, Mohammed K Nagshabandi, Muyassar K Tarabulsi, Saad M Almuhayawi, Soad K Al Jaouni, Samy Selim, Awadh Alanazi, Yasir Alruwaili, Osama Ahmed Faried, Islam Amin, Mohamed E Elnosary. Molecular Profile and the Effectiveness of Antimicrobials Drugs Against Staphylococcus aureus and Pseudomonas aeruginosa in the Diagnostic Approaches of Otitis Infection. Infection and Drug Resistance 2023, Volume 16 , 4397-4408. https://doi.org/10.2147/IDR.S418685
  18. Marisa L. Guido, Thomas P. Kelly, Nicholas J. Bongio, David J. Lampe. Paratransgenesis in Mosquitoes and Other Insects: Microbial Ecology and Bacterial Genetic Considerations. 2022, 320-339. https://doi.org/10.1079/9781800621176.0016
  19. Dukas Jurėnas, Nathan Fraikin, Frédéric Goormaghtigh, Laurence Van Melderen. Biology and evolution of bacterial toxin–antitoxin systems. Nature Reviews Microbiology 2022, 20 (6) , 335-350. https://doi.org/10.1038/s41579-021-00661-1
  20. Claudia F. Moratti, Colin Scott, Nicholas V. Coleman. Synthetic Biology Approaches to Hydrocarbon Biosensors: A Review. Frontiers in Bioengineering and Biotechnology 2022, 9 https://doi.org/10.3389/fbioe.2021.804234
  21. Xinyi Wan, Trevor Y. H. Ho, Baojun Wang. Engineering Prokaryote Synthetic Biology Biosensors. 2022, 283-318. https://doi.org/10.1007/978-3-030-23217-7_131
  22. Ke Yan Wen, Jack W. Rutter, Chris P. Barnes, Linda Dekker. Fundamental Building Blocks of Whole-Cell Biosensor Design. 2022, 383-405. https://doi.org/10.1007/978-3-030-23217-7_181
  23. Nedim Hacıosmanoğlu, Sıla Köse, Julian Ostaku, İlkay Çisil Köksaldi, Behide Saltepe, Urartu Özgür Şafak Şeker. Design of synthetic biological devices for detection and targeting human diseases. 2022, 251-269. https://doi.org/10.1016/B978-0-12-824469-2.00028-2
  24. Behide Saltepe, Lei Wang, Baojun Wang. Synthetic biology enables field-deployable biosensors for water contaminants. TrAC Trends in Analytical Chemistry 2022, 146 , 116507. https://doi.org/10.1016/j.trac.2021.116507
  25. Shimshon Belkin, Baojun Wang. Sense and sensibility: of synthetic biology and the redesign of bioreporter circuits. Microbial Biotechnology 2022, 15 (1) , 103-106. https://doi.org/10.1111/1751-7915.13955
  26. Xinyi Wan, Behide Saltepe, Luyang Yu, Baojun Wang. Programming living sensors for environment, health and biomanufacturing. Microbial Biotechnology 2021, 14 (6) , 2334-2342. https://doi.org/10.1111/1751-7915.13820
  27. Masahito Ishikawa, Takaaki Kojima, Katsutoshi Hori, . Development of a Biocontained Toluene-Degrading Bacterium for Environmental Protection. Microbiology Spectrum 2021, 9 (1) https://doi.org/10.1128/Spectrum.00259-21
  28. Tzu-Chieh Tang, Eléonore Tham, Xinyue Liu, Kevin Yehl, Alexis J. Rovner, Hyunwoo Yuk, Cesar de la Fuente-Nunez, Farren J. Isaacs, Xuanhe Zhao, Timothy K. Lu. Hydrogel-based biocontainment of bacteria for continuous sensing and computation. Nature Chemical Biology 2021, 17 (6) , 724-731. https://doi.org/10.1038/s41589-021-00779-6
  29. Marcos Valenzuela-Ortega, Christopher French. Joint universal modular plasmids (JUMP): a flexible vector platform for synthetic biology. Synthetic Biology 2021, 6 (1) https://doi.org/10.1093/synbio/ysab003
  30. Jinpeng Liu, Nali Zhu, Youjun Zhang, Tongtong Ren, Chaofeng Shao, Rongguang Shi, Xiaohua Li, Meiting Ju, Ting Ma, Qilin Yu. Transcription profiling-guided remodeling of sulfur metabolism in synthetic bacteria for efficiently capturing heavy metals. Journal of Hazardous Materials 2021, 403 , 123638. https://doi.org/10.1016/j.jhazmat.2020.123638
  31. Benjamin Shemer, Etai Shpigel, Carina Hazan, Yossef Kabessa, Aharon J. Agranat, Shimshon Belkin. Detection of buried explosives with immobilized bacterial bioreporters. Microbial Biotechnology 2021, 14 (1) , 251-261. https://doi.org/10.1111/1751-7915.13683
  32. Donghyeon Kim, Jeong Wook Lee. Genetic Biocontainment Systems for the Safe Use of Engineered Microorganisms. Biotechnology and Bioprocess Engineering 2020, 25 (6) , 974-984. https://doi.org/10.1007/s12257-020-0070-1
  33. Teng Wang, Lingchong You. The persistence potential of transferable plasmids. Nature Communications 2020, 11 (1) https://doi.org/10.1038/s41467-020-19368-7
  34. Michael T. Parker, Aditya M. Kunjapur. Deployment of Engineered Microbes: Contributions to the Bioeconomy and Considerations for Biosecurity. Health Security 2020, 18 (4) , 278-296. https://doi.org/10.1089/hs.2020.0010
  35. Jiahua Pu, Yi Liu, Jicong Zhang, Bolin An, Yingfeng Li, Xinyu Wang, Kang Din, Chong Qin, Ke Li, Mengkui Cui, Suying Liu, Yuanyuan Huang, Yanyi Wang, Yanan Lv, Jiaofang Huang, Zongqiang Cui, Suwen Zhao, Chao Zhong. Virus Disinfection from Environmental Water Sources Using Living Engineered Biofilm Materials. Advanced Science 2020, 7 (14) https://doi.org/10.1002/advs.201903558
  36. Julián I. Mendoza, Fernando C. Soncini, Susana K. Checa. Engineering of a Au-sensor to develop a Hg-specific, sensitive and robust whole-cell biosensor for on-site water monitoring. Chemical Communications 2020, 56 (48) , 6590-6593. https://doi.org/10.1039/D0CC01323D
  37. Finn Stirling, Pamela A. Silver. Controlling the Implementation of Transgenic Microbes: Are We Ready for What Synthetic Biology Has to Offer?. Molecular Cell 2020, 78 (4) , 614-623. https://doi.org/10.1016/j.molcel.2020.03.034
  38. Maggie Hicks, Till T. Bachmann, Baojun Wang. Synthetic Biology Enables Programmable Cell‐Based Biosensors. ChemPhysChem 2020, 21 (2) , 132-144. https://doi.org/10.1002/cphc.201900739
  39. Marcos Valenzuela-Ortega, Christopher E. French. Joint Universal Modular Plasmids: A Flexible Platform for Golden Gate Assembly in Any Microbial Host. 2020, 255-273. https://doi.org/10.1007/978-1-0716-0908-8_15
  40. Ke Yan Wen, Jack W. Rutter, Chris P. Barnes, Linda Dekker. Fundamental Building Blocks of Whole-Cell Biosensor Design. 2020, 1-23. https://doi.org/10.1007/978-3-319-47405-2_181-1
  41. Luísa Czamanski Nora, Cauã Antunes Westmann, María-Eugenia Guazzaroni, Chandranayaka Siddaiah, Vijai Kumar Gupta, Rafael Silva-Rocha. Recent advances in plasmid-based tools for establishing novel microbial chassis. Biotechnology Advances 2019, 37 (8) , 107433. https://doi.org/10.1016/j.biotechadv.2019.107433
  42. Markus Schmidt. A metric space for semantic containment: Towards the implementation of genetic firewalls. Biosystems 2019, 185 , 104015. https://doi.org/10.1016/j.biosystems.2019.104015
  43. Lucía Gómez-Tatay, José M. Hernández-Andreu. Biosafety and biosecurity in Synthetic Biology: A review. Critical Reviews in Environmental Science and Technology 2019, 49 (17) , 1587-1621. https://doi.org/10.1080/10643389.2019.1579628
  44. Xinyi Wan, Trevor Y. H. Ho, Baojun Wang. Engineering Prokaryote Synthetic Biology Biosensors. 2019, 1-37. https://doi.org/10.1007/978-3-319-47405-2_131-1
  45. Ryuichi Hirota, Kei Motomura, Akio Kuroda. Biological Phosphite Oxidation and Its Application to Phosphorus Recycling. 2019, 499-513. https://doi.org/10.1007/978-981-10-8031-9_34
  46. Haisi Dong, Hua Xiang, Dan Mu, Dacheng Wang, Tiedong Wang. Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. International Journal of Antimicrobial Agents 2019, 53 (1) , 1-8. https://doi.org/10.1016/j.ijantimicag.2018.09.017
  47. Luísa Czamanski Nora, Cauã Antunes Westmann, Leonardo Martins‐Santana, Luana de Fátima Alves, Lummy Maria Oliveira Monteiro, María‐Eugenia Guazzaroni, Rafael Silva‐Rocha. The art of vector engineering: towards the construction of next‐generation genetic tools. Microbial Biotechnology 2019, 12 (1) , 125-147. https://doi.org/10.1111/1751-7915.13318
  48. Christopher M. Whitford, Saskia Dymek, Denise Kerkhoff, Camilla März, Olga Schmidt, Maximilian Edich, Julian Droste, Boas Pucker, Christian Rückert, Jörn Kalinowski. Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications. Journal of Biological Engineering 2018, 12 (1) https://doi.org/10.1186/s13036-018-0105-8
  49. Hadiastri Kusumawardhani, Rohola Hosseini, Johannes H. de Winde. Solvent Tolerance in Bacteria: Fulfilling the Promise of the Biotech Era?. Trends in Biotechnology 2018, 36 (10) , 1025-1039. https://doi.org/10.1016/j.tibtech.2018.04.007
  50. Vincent M Isabella, Binh N Ha, Mary Joan Castillo, David J Lubkowicz, Sarah E Rowe, Yves A Millet, Cami L Anderson, Ning Li, Adam B Fisher, Kip A West, Philippa J Reeder, Munira M Momin, Christopher G Bergeron, Sarah E Guilmain, Paul F Miller, Caroline B Kurtz, Dean Falb. Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria. Nature Biotechnology 2018, 36 (9) , 857-864. https://doi.org/10.1038/nbt.4222
  51. Zepeng Mu, Zhuoning Zou, Ye Yang, Wenbo Wang, Yue Xu, Jianyi Huang, Ruiling Cai, Ye Liu, Yajin Mo, Boyi Wang, Yiqun Dang, Yongming Li, Yushan Liu, Yueren Jiang, Qingyang Tan, Xiaohong Liu, Cheng Hu, Hua Li, Sha Wei, Chunbo Lou, Yang Yu, Jiangyun Wang. A genetically engineered Escherichia coli that senses and degrades tetracycline antibiotic residue. Synthetic and Systems Biotechnology 2018, 3 (3) , 196-203. https://doi.org/10.1016/j.synbio.2018.05.001
  52. Chiqian Zhang, Damien Parrello, Pamela J. B. Brown, Judy D. Wall, Zhiqiang Hu. A novel whole-cell biosensor of Pseudomonas aeruginosa to monitor the expression of quorum sensing genes. Applied Microbiology and Biotechnology 2018, 102 (14) , 6023-6038. https://doi.org/10.1007/s00253-018-9044-z
  53. Tanel Ozdemir, Alex J.H. Fedorec, Tal Danino, Chris P. Barnes. Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity. Cell Systems 2018, 7 (1) , 5-16. https://doi.org/10.1016/j.cels.2018.06.008
  54. Lei Pei, Markus Schmidt. Fast-Growing Engineered Microbes: New Concerns for Gain-of-Function Research?. Frontiers in Genetics 2018, 9 https://doi.org/10.3389/fgene.2018.00207
  55. Jeong Wook Lee, Clement T. Y. Chan, Shimyn Slomovic, James J. Collins. Next-generation biocontainment systems for engineered organisms. Nature Chemical Biology 2018, 14 (6) , 530-537. https://doi.org/10.1038/s41589-018-0056-x
  56. Victoria Hsiao, Anandh Swaminathan, Richard M. Murray. Control Theory for Synthetic Biology: Recent Advances in System Characterization, Control Design, and Controller Implementation for Synthetic Biology. IEEE Control Systems 2018, 38 (3) , 32-62. https://doi.org/10.1109/MCS.2018.2810459
  57. Aditya M. Kunjapur, Devon A. Stork, Erkin Kuru, Oscar Vargas-Rodriguez, Matthieu Landon, Dieter Söll, George M. Church. Engineering posttranslational proofreading to discriminate nonstandard amino acids. Proceedings of the National Academy of Sciences 2018, 115 (3) , 619-624. https://doi.org/10.1073/pnas.1715137115
  58. Jara Radeck, Daniel Meyer, Nina Lautenschläger, Thorsten Mascher. Bacillus SEVA siblings: A Golden Gate-based toolbox to create personalized integrative vectors for Bacillus subtilis. Scientific Reports 2017, 7 (1) https://doi.org/10.1038/s41598-017-14329-5
  59. Ryuichi Hirota, Kenji Abe, Zen-ichiro Katsuura, Reiji Noguchi, Shigeaki Moribe, Kei Motomura, Takenori Ishida, Maxym Alexandrov, Hisakage Funabashi, Takeshi Ikeda, Akio Kuroda. A Novel Biocontainment Strategy Makes Bacterial Growth and Survival Dependent on Phosphite. Scientific Reports 2017, 7 (1) https://doi.org/10.1038/srep44748
  60. Alexander J. Webb, Richard Kelwick, Paul S. Freemont. Opportunities for applying whole‐cell bioreporters towards parasite detection. Microbial Biotechnology 2017, 10 (2) , 244-249. https://doi.org/10.1111/1751-7915.12604
  61. Neta Agmon, Zuojian Tang, Kun Yang, Ben Sutter, Shigehito Ikushima, Yizhi Cai, Katrina Caravelli, James A. Martin, Xiaoji Sun, Woo Jin Choi, Allen Zhang, Giovanni Stracquadanio, Haiping Hao, Benjamin P. Tu, David Fenyo, Joel S. Bader, Jef D. Boeke. Low escape-rate genome safeguards with minimal molecular perturbation of Saccharomyces cerevisiae. Proceedings of the National Academy of Sciences 2017, 114 (8) https://doi.org/10.1073/pnas.1621250114
  62. Markus Schmidt, Lei Pei, Nediljko Budisa. Xenobiology: State-of-the-Art, Ethics, and Philosophy of New-to-Nature Organisms. 2017, 301-315. https://doi.org/10.1007/10_2016_14
  63. M. Klemenčič, A.Z. Nielsen, Y. Sakuragi, N.-U. Frigaard, H. Čelešnik, P.E. Jensen, M. Dolinar. Synthetic biology of cyanobacteria for production of biofuels and high-value products. 2017, 305-325. https://doi.org/10.1016/B978-0-08-101023-5.00013-3
  64. Barnabas James Walker, Guy-Bart V. Stan, Karen Marie Polizzi. Intracellular delivery of biologic therapeutics by bacterial secretion systems. Expert Reviews in Molecular Medicine 2017, 19 https://doi.org/10.1017/erm.2017.7
  65. , Leticia Torres, Antje Krüger, Eszter Csibra, Edoardo Gianni, Vitor B. Pinheiro. Synthetic biology approaches to biological containment: pre-emptively tackling potential risks. Essays in Biochemistry 2016, 60 (4) , 393-410. https://doi.org/10.1042/EBC20160013
  66. Helena Čelešnik, Anja Tanšek, Aneja Tahirović, Angelika Vižintin, Jernej Mustar, Vita Vidmar, Marko Dolinar. Biosafety of biotechnologically important microalgae: intrinsic suicide switch implementation in cyanobacterium Synechocystis sp . PCC 6803. Biology Open 2016, 5 (4) , 519-528. https://doi.org/10.1242/bio.017129
  67. Markus Schmidt, Víctor de Lorenzo. Synthetic bugs on the loose: containment options for deeply engineered (micro)organisms. Current Opinion in Biotechnology 2016, 38 , 90-96. https://doi.org/10.1016/j.copbio.2016.01.006
  68. Ophelia S. Venturelli, Robert G. Egbert, Adam P. Arkin. Towards Engineering Biological Systems in a Broader Context. Journal of Molecular Biology 2016, 428 (5) , 928-944. https://doi.org/10.1016/j.jmb.2015.10.025
  69. Clement T Y Chan, Jeong Wook Lee, D Ewen Cameron, Caleb J Bashor, James J Collins. 'Deadman' and 'Passcode' microbial kill switches for bacterial containment. Nature Chemical Biology 2016, 12 (2) , 82-86. https://doi.org/10.1038/nchembio.1979
  70. Karmella A Haynes. Building genetic containment. Nature Chemical Biology 2016, 12 (2) , 55-56. https://doi.org/10.1038/nchembio.2004
  71. Páraic Ó Cuív, Sriti Burman, Sian Pottenger, Mark Morrison. Exploring the Bioactive Landscape of the Gut Microbiota to Identify Metabolites Underpinning Human Health. 2016, 49-82. https://doi.org/10.1007/978-3-319-46326-1_3
  72. Anna J. Simon, Andrew D. Ellington. Recent advances in synthetic biosafety. F1000Research 2016, 5 , 2118. https://doi.org/10.12688/f1000research.8365.1
  73. Carlos Piñero-Lambea, David Ruano-Gallego, Luis Ángel Fernández. Engineered bacteria as therapeutic agents. Current Opinion in Biotechnology 2015, 35 , 94-102. https://doi.org/10.1016/j.copbio.2015.05.004
  74. Richard Kelwick, Laura Bowater, Kay H. Yeoman, Richard P. Bowater, . Promoting microbiology education through the iGEM synthetic biology competition. FEMS Microbiology Letters 2015, 362 (16) , fnv129. https://doi.org/10.1093/femsle/fnv129
  75. Esteban Martínez-García, Ilaria Benedetti, Angeles Hueso, Víctor de Lorenzo. Mining Environmental Plasmids for Synthetic Biology Parts and Devices. 2015, 633-649. https://doi.org/10.1128/9781555818982.ch32
  76. Esteban Martínez-García, Ilaria Benedetti, Angeles Hueso, Víctor De Lorenzo, , . Mining Environmental Plasmids for Synthetic Biology Parts and Devices. Microbiology Spectrum 2015, 3 (1) https://doi.org/10.1128/microbiolspec.PLAS-0033-2014
  77. Daniel J. Mandell, Marc J. Lajoie, Michael T. Mee, Ryo Takeuchi, Gleb Kuznetsov, Julie E. Norville, Christopher J. Gregg, Barry L. Stoddard, George M. Church. Biocontainment of genetically modified organisms by synthetic protein design. Nature 2015, 518 (7537) , 55-60. https://doi.org/10.1038/nature14121
  78. Markus Schmidt, Lei Pei. Improving Biocontainment with Synthetic Biology: Beyond Physical Containment. 2015, 185-199. https://doi.org/10.1007/8623_2015_90
  79. Yusuke Kato. An engineered bacterium auxotrophic for an unnatural amino acid: a novel biological containment system. PeerJ 2015, 3 , e1247. https://doi.org/10.7717/peerj.1247
  80. Richard Kelwick, James T. MacDonald, Alexander J. Webb, Paul Freemont. Developments in the Tools and Methodologies of Synthetic Biology. Frontiers in Bioengineering and Biotechnology 2014, 2 https://doi.org/10.3389/fbioe.2014.00060
  • Abstract

    Figure 1

    Figure 1. Flow cytometry of DIAL strains hosting COR reporter plasmids. (a) Schematic of COR plasmid dependence on host DIAL strain, where plasmid copy number is tuned by the ribosome binding site (RBS) strength of the replication initiator protein transcript. (b) DIAL strains constitutively expressing both π and RepA at low (AB), medium (EI) and high (JK) levels were transformed with mRFP1 reporter plasmids containing the R6K (pSEVA117Rb) or ColE2 (pSEVA177Rb) COR, and fluorescence assessed at mid log growth phase by flow cytometry. Low-copy RK2 (pSEVA127Rb) and high-copy pUC (pSEVA167Rb) origins were also profiled as controls. Median fluorescence values and robust coefficient of variation (rCV) are indicated beneath each plot (n = 4 biological repeats; representatives shown). W/T, wild-type E. coli MC1061 used for DIAL strain construction; au, arbitrary units; X-axis, side scatter; RBS EI, RBS E for π, RBS I for RepA (see Supporting Information Table 1 for more detail).

    Figure 2

    Figure 2. Plasmid stability in auxotrophic strains. (a) Schematic of DIAL strain auxotroph (ΔthyA or ΔdapA) dependence on complementing plasmid (thyA+ or dapA+). Orange arrow indicates complementation of knocked-out gene (remnants represented by orange bars on chromosome). (b) Stability assay measuring the proportion of colonies that retain their plasmid in low-copy DIAL strain AB after ∼100 generations in liquid LB without antibiotic selection (n = 4 biological repeats; error bars = standard deviation). (c) Assay as above, but plated on agar containing key metabolite to assess plasmid stability when auxotrophic pressure is removed (n = 4 biological repeats; error bars = standard deviation). (d) Assessment nonsterile soil’s ability to provide key metabolite to auxotrophs when added to liquid SOB and incubated overnight (dilution series subsequently plated on kanamycin-containing LB agar to suppress growth of other soil microbes). kanR, kanamycin resistance cassette; dark purple bars, FRT (flippase recognition target); thyd., thymidine; DAP, diaminopimelic acid; KO, knockout; R6K (pSEVA117Rb), ColE2 (pSEVA177Rb), R6K-thyA (pSEVA117RbT), ColE2-thyA (pSEVA177RbT), R6K-dapA (pSEVA117RbD), ColE2-dapA (pSEVA177RbD), low RK2 (pSEVA127Rb), high pUC (pSEVA167Rb) (see Supporting Information Table 1 for more detail).

    Figure 3

    Figure 3. Use of ζ–ε and Kid-Kis toxin–antitoxin pairs. (a) Schematic of how a toxin-encoding plasmid may prove deleterious if taken up by wild-type cells, while the specified host cell possesses genome-encoded immunity. (b) Growth curves of high-copy DIAL strain JK with various combinations of ΔdapA auxotrophy, chromosomally integrated ε or Kis antitoxin, and plasmid-encoded ζ or Kid toxin (ColE2 COR used; n = 3 biological repeats; error bars = standard deviation). For ΔthyA auxotrophy, and other plasmid copy numbers, see Supporting Information Figure 2. (c) Western blot of various DIAL strains constitutively expressing integrated ε (11.5 kDa) or Kis (10.2 kDa) antitoxins alone, as well as with plasmid-encoded ζ (33.2 kDa) or Kid (12.7 kDa) toxins. All toxins/antitoxins are His-tagged at the C-terminus; putative toxin bands are arrowed. (d) Transformation assessment of ability of wild-type cells to maintain toxin plasmid in the absence of integrated antitoxin. W/T, wild-type; antiT, antitoxin; WM, weight marker; dapA (pSEVA177RbD); dapA-ζ (pSEVA177RbDZh); dapA-Kid (pSEVA177RbDKh); control plasmid (pSEVA3b61); ζ plasmid (pSEVA3b6Zh); Kid plasmid (pSEVA3b6Kh).

    Figure 4

    Figure 4. Schematic of the GeneGuard system. The genomic cassette (a) consists of replication initiator, antitoxin and FRT-bound kanamycin resistance genes, flanked by ∼280 to 500 bp of 5′/3′ UTR sequence from the thyA or dapA genes (total cassette size of ∼3.6–3.8 kbp). The vector cassette (b) hosts cargo DNA via a pUC18-derived multicloning site that contains a removable antibiotic resistance gene between the PacI and AvrII sites. To retrofit existing plasmids, the COR/toxin/auxotrophy cassette (c) may be PCR-amplified and swapped with the existing origin/antibiotic resistance region. After construction, GeneGuard-derived plasmids are dependent on host cells that contain the requisite genomic cassette (d).

    Figure 5

    Figure 5. GeneGuard system applied to heavy-metal biosensors. (a) Schematic of biosensors inserted into GeneGuard plasmids. Arsenic relieves ArsR repression of ParsR; mercury relieves MerR repression of PmerT; and copper enables CusR activation of PcusC. Each of these promoters is linked to the reporter GFPmut3b. (b) Dose response curves in E. coli DH10B for the arsenic biosensor in its original plasmid (pSB3K3 contains a medium-copy p15A origin, requires kanamycin selection), and its performance when ported to GeneGuard variants pD1K (dapA, R6K COR, Kid toxin; no antibiotic selection used) and pT7Z (thyA, ColE2 COR, ζ toxin; no antibiotic selection used) with the requisite genomic cassettes inserted to support a medium-copy plasmid number (n = 4 biological repeats; error bars = standard deviation). (c) Dose response curves for the mercury biosensor, as per part b. (d) Dose response curves for the copper biosensor, as per part b. W/T, wild-type; au, arbitrary units; WHO, World Health Organization. (43) For low and high-copy GeneGuard plasmid results, see Supporting Information Figure 3.

  • References

    ARTICLE SECTIONS
    Jump To

    This article references 55 other publications.

    1. 1
      Martin, V. J. J., Pitera, D. J., Withers, S. T., Newman, J. D., and Keasling, J. D. (2003) Engineering a mevalonate pathway in Escherichia coli for production of terpenoids Nat. Biotechnol. 21, 796 802
    2. 2
      French, C. E., de Mora, K., Joshi, N., Elfick, A., Haseloff, J., and Ajioka, J. (2011) Synthetic biology and the art of biosensor design. In The Science and Applications of Synthetic and Systems Biology: Workshop Summary, pp 178 201, National Academies Press, Washington DC; NCBI bookshelf ID NBK84465.
    3. 3
      Singh, J. S., Abhilash, P. C., Singh, H. B., Singh, R. P., and Singh, D. P. (2011) Genetically engineered bacteria: An emerging tool for environmental remediation and future research perspectives Gene 480, 1 9
    4. 4
      Brune, K. D. and Bayer, T. S. (2012) Engineering microbial consortia to enhance biomining and bioremediation Front. Microbiol. 3, 203
    5. 5
      Moe-Behrens, G. H. G., Davis, R., and Haynes, K. A. (2013) Preparing synthetic biology for the world Front. Microbiol. 4, 5
    6. 6
      Wright, O., Stan, G.-B., and Ellis, T. (2013) Building-in biosafety for synthetic biology Microbiology 159, 1221 1235
    7. 7
      Lajoie, M. J., Rovner, A. J., Goodman, D. B., Aerni, H. R., Haimovich, A. D., Kuznetsov, G., Mercer, J. A., Wang, H. H., Carr, P. A., Mosberg, J. A., Rohland, N., Schultz, P. G., Jacobson, J. M., Rinehart, J., Church, G. M., and Isaacs, F. J. (2013) Genomically recoded organisms expand biological functions Science 342, 357 360
    8. 8
      Schmidt, M. (2010) Xenobiology: A new form of life as the ultimate biosafety tool Bioessays 32, 322 331
    9. 9
      Benner, S. A. and Sismour, A. M. (2005) Synthetic biology Nat. Rev. Genet. 6, 533 543
    10. 10
      Silva-Rocha, R., Martínez-García, E., Calles, B., Chavarría, M., Arce-Rodríguez, A., Las de Heras, A., Páez-Espino, A. D., Durante-Rodríguez, G., Kim, J., Nikel, P. I., Platero, R., and de Lorenzo, V. (2012) The Standard European Vector Architecture (SEVA): A coherent platform for the analysis and deployment of complex prokaryotic phenotypes Nucleic Acids Res. 41, D666 D675
    11. 11
      Mutalik, V. K., Guimaraes, J. C., Cambray, G., Lam, C., Christoffersen, M. J., Mai, Q.-A., Tran, A. B., Paull, M., Keasling, J. D., Arkin, A. P., and Endy, D. (2013) Precise and reliable gene expression via standard transcription and translation initiation elements Nat. Methods 10, 354 360
    12. 12
      Zhang, X.-Z. and Zhang, Y. H. P. (2011) Simple, fast and high-efficiency transformation system for directed evolution of cellulase in Bacillus subtilis Microb. Biotechnol. 4, 98 105
    13. 13
      Filutowicz, M., McEachern, M. J., and Helinski, D. R. (1986) Positive and negative roles of an initiator protein at an origin of replication Proc. Natl. Acad. Sci. U.S.A. 83, 9645 9649
    14. 14
      Hiraga, S., Sugiyama, T., and Itoh, T. (1994) Comparative analysis of the replicon regions of eleven ColE2-related plasmids J. Bacteriol. 176, 7233 7243
    15. 15
      Kittleson, J. T., Cheung, S., and Anderson, J. C. (2011) Rapid optimization of gene dosage in E. coli using DIAL strains J. Biol. Eng. 5, 10
    16. 16
      Durland, R. H. and Helinski, D. R. (1990) Replication of the broad-host-range plasmid RK2: Direct measurement of intracellular concentrations of the essential TrfA replication proteins and their effect on plasmid copy number J. Bacteriol. 172, 3849 3858
    17. 17
      Miki, T., Yasukochi, T., Nagatani, H., Furuno, M., Orita, T., Yamada, H., Imoto, T., and Horiuchi, T. (1987) Construction of a plasmid vector for the regulatable high level expression of eukaryotic genes in Escherichia coli: An application to overproduction of chicken lysozyme Protein Eng. 1, 327 332
    18. 18
      Lin-Chao, S., Chen, W.-T., and Wong, T.-T. (1992) High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II Mol. Microbiol. 6, 3385 3393
    19. 19
      Wong, Q. N. Y., Ng, V. C. W., Lin, M. C. M., Kung, H.-F., Chan, D., and Huang, J.-D. (2005) Efficient and seamless DNA recombineering using a thymidylate synthase A selection system in Escherichia coli Nucleic Acids Res. 33, e59
    20. 20
      Acord, J. and Masters, M. (2004) Expression from the Escherichia coli dapA promoter is regulated by intracellular levels of diaminopimelic acid FEMS Microbiol. Lett. 235, 131 137
    21. 21
      Datsenko, K. A. and Wanner, B. L. (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products Proc. Natl. Acad. Sci. U.S.A. 97, 6640 6645
    22. 22
      Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K. A., Tomita, M., Wanner, B. L., and Mori, H. (2006) Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: The Keio collection Mol. Syst. Biol. 2, 0008
    23. 23
      Shetty, R. P., Endy, D., and Knight, T. F. (2008) Engineering BioBrick vectors from BioBrick parts J. Biol. Eng. 2, 5
    24. 24
      Silby, M. W. and Levy, S. B. (2004) Use of in vivo expression technology to identify genes important in growth and survival of Pseudomonas fluorescens Pf0-1 in soil: Discovery of expressed sequences with novel genetic organization J. Bacteriol. 186, 7411 7419
    25. 25
      Varivarn, K., Champa, L. A., Silby, M. W., and Robleto, E. A. (2013) Colonization strategies of Pseudomonas fluorescens Pf0-1: Activation of soil-specific genes important for diverse and specific environments BMC Microbiol. 13, 92
    26. 26
      Molin, S., Boe, L., Jensen, L. B., Kristensen, C. S., Givskov, M., Ramos, J. L., and Bej, A. K. (1993) Suicidal genetic elements and their use in biological containment of bacteria Annu. Rev. Microbiol. 47, 139 166
    27. 27
      Zielenkiewicz, U. and Ceglowski, P. (2005) The toxin–antitoxin system of the streptococcal plasmid pSM19035 J. Bacteriol. 187, 6094 6105
    28. 28
      Zielenkiewicz, U., Kowalewska, M., Kaczor, C., and Ceglowski, P. (2009) In vivo interactions between toxin–antitoxin proteins epsilon and zeta of streptococcal plasmid pSM19035 in Saccharomyces cerevisiae J. Bacteriol. 191, 3677 3684
    29. 29
      de la Cueva-Méndez, G., Mills, A. D., Clay-Farrace, L., Díaz-Orejas, R., and Laskey, R. A. (2003) Regulatable killing of eukaryotic cells by the prokaryotic proteins Kid and Kis EMBO J. 22, 246 251
    30. 30
      Mutschler, H., Gebhardt, M., Shoeman, R. L., and Meinhart, A. (2011) A novel mechanism of programmed cell death in bacteria by toxin–antitoxin systems corrupts peptidoglycan synthesis PLoS Biol. 9, e1001033
    31. 31
      Pimentel, B., Madine, M. A., and de la Cueva-Méndez, G. (2005) Kid cleaves specific mRNAs at UUACU sites to rescue the copy number of plasmid R1 EMBO J. 24, 3459 3469
    32. 32
      Salis, H. M., Mirsky, E. A., and Voigt, C. A. (2009) Automated design of synthetic ribosome binding sites to control protein expression Nat. Biotechnol. 27, 946 950
    33. 33
      Casini, A., MacDonald, J. T., Jonghe, J. D., Christodoulou, G., Freemont, P. S., Baldwin, G. S., and Ellis, T. (2013) One-pot DNA construction for synthetic biology: The Modular Overlap-Directed Assembly with Linkers (MODAL) strategy Nucleic Acids Res. 42, e7
    34. 34
      de la Cueva-Méndez, G. and Pimentel, B. (2007) Gene and cell survival: Lessons from prokaryotic plasmid R1 EMBO Rep. 8, 458 464
    35. 35
      Olson, D. G. and Lynd, L. R. (2012) Computational design and characterization of a temperature-sensitive plasmid replicon for gram positive thermophiles J. Biol. Eng. 6, 5
    36. 36
      Pellegrini, O., Mathy, N., Gogos, A., Shapiro, L., and Condon, C. (2005) The Bacillus subtilis ydcDE operon encodes an endoribonuclease of the MazF/PemK family and its inhibitor Mol. Microbiol. 56, 1139 1148
    37. 37
      Wang, B., Barahona, M., and Buck, M. (2013) A modular cell-based biosensor using engineered genetic logic circuits to detect and integrate multiple environmental signals Biosens. Bioelectron. 40, 368 376
    38. 38
      Friedland, A. E., Lu, T. K., Wang, X., Shi, D., Church, G., and Collins, J. J. (2009) Synthetic gene networks that count Science 324, 1199 1202
    39. 39
      Callura, J. M., Dwyer, D. J., Isaacs, F. J., Cantor, C. R., and Collins, J. J. (2010) Tracking, tuning, and terminating microbial physiology using synthetic riboregulators Proc. Natl. Acad. Sci. U.S.A. 107, 15898 15903
    40. 40
      Ronchel, M. C. and Ramos, J. L. (2001) Dual system to reinforce biological containment of recombinant bacteria designed for rhizoremediation Appl. Environ. Microbiol. 67, 2649 2656
    41. 41
      Neuhard, J., Price, A. R., Schack, L., and Thomassen, E. (1978) Two thymidylate synthetases in Bacillus subtilis Proc. Natl. Acad. Sci. U.S.A. 75, 1194 1198
    42. 42
      Marris, C. and Jefferson, C. (2013) Synthetic Biology: Containment and Release of Engineered Micro-organisms. Workshop held at King’s College London, 29th April 2013. Summary of discussions available from http://www.kcl.ac.uk/sspp/departments/sshm/research/Research-Labs/CSynBi-Events.aspx.
    43. 43
      World Health Organization. ( (2011) Guidelines for Drinking-Water Quality, 4th ed., WHO Press, Geneva. Available from http://www.who.int/.
    44. 44
      Kang, H. Y., Dozois, C. M., Tinge, S. A., Lee, T. H., and Curtiss, R., III (2002) Transduction-mediated transfer of unmarked deletion and point mutations through use of counterselectable suicide vectors J. Bacteriol. 184, 307 312
    45. 45
      Sat, B., Reches, M., and Engelberg-Kulka, H. (2003) The Escherichia coli mazEF suicide module mediates thymineless death J. Bacteriol. 185, 1803 1807
    46. 46
      Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., Cox, E., Remon, J. P., and Remaut, E. (2003) Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10 Nat. Biotechnol. 21, 785 789
    47. 47
      Don, R. H., Cox, P. T., Wainwright, B. J., Baker, K., and Mattick, J. S. (1991) Touchdown PCR to circumvent spurious priming during gene amplification Nucleic Acids Res. 19, 4008
    48. 48
      Stemmer, W. P., Crameri, A., Ha, K. D., Brennan, T. M., and Heyneker, H. L. (1995) Single-step assembly of a gene and entire plasmid from large numbers of oligodeoxyribonucleotides Gene 164, 49 53
    49. 49
      Kuhlman, T. E. and Cox, E. C. (2010) Site-specific chromosomal integration of large synthetic constructs Nucleic Acids Res. 38, e92
    50. 50
      Imamura, N. and Nakayama, H. (1982) thiK and thiL loci of Escherichia coli J. Bacteriol. 151, 708 717
    51. 51
      Webb, E. and Downs, D. (1997) Characterization of thiL, encoding thiamin-monophosphate kinase Salmonella typhimurium J. Biol. Chem. 272, 15702 15707
    52. 52
      Schyns, G., Potot, S., Geng, Y., Barbosa, T. M., Henriques, A., and Perkins, J. B. (2005) Isolation and characterization of new thiamine-deregulated mutants of Bacillus subtilis J. Bacteriol. 187, 8127 8136
    53. 53
      Domínguez, M. C., La Rosa, de M., and Borobio, M. V. (2001) Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar J. Antimicrob. Chemother. 47, 391 398
    54. 54
      Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227, 680 685
    55. 55
      Bravo, A., Torrontegui, G., and Díaz, R. (1987) Identification of components of a new stability system of plasmid R1, ParD, that is close to the origin of replication of this plasmid Mol. Gen. Genet. 210, 101 110
  • Supporting Information

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    Supplementary figures, sequence tables, GenBank accession numbers, and annotated plasmid ApE files (ApE can be downloaded for free at http://biologylabs.utah.edu/jorgensen/wayned/ape/). This material is available free of charge via the Internet at http://pubs.acs.org. In addition, selected GeneGuard plasmids may be obtained from the SEVA repository by request (see http://seva.cnb.csic.es/).


    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect